EMS Q2 FY26 – Weak Quarter with Sharp Declines Across All Key Metrics

EMS reported a subdued September 2025 quarter, with double-digit YoY declines in revenue, operating profit, and net earnings, reflecting pressure on execution and margins. Sales: ↓ 26% YoY to ₹172 crore (vs ₹233 crore in Sep 2024) EBIDT: ↓ 47% YoY to ₹36.2 crore (vs ₹68.5 crore) Net Profit: ↓ 43% YoY to ₹28.1 crore (vs ₹49.6 crore) EPS: ↓ 43% YoY to ₹5.09 (vs ₹8.94) At a price of ₹438, market cap ₹2,424 crore, and PE 14.9, EMS shows notable softening in financial performance, driven by lower revenue execution and declining profitability.